(0.71%) 5 082.50 points
(0.45%) 38 241 points
(0.95%) 17 604 points
(0.56%) $79.44
(1.60%) $1.963
(-0.06%) $2 309.70
(-0.72%) $26.56
(0.49%) $959.60
(0.17%) $0.935
(0.45%) $11.08
(0.11%) $0.799
(-1.60%) $91.77
0.40% € 149.55
Live Chart Being Loaded With Signals
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology...
Stats | |
---|---|
Tagesvolumen | 85 830.00 |
Durchschnittsvolumen | 274 172 |
Marktkapitalisierung | 65.24B |
EPS | €0 ( 2024-03-06 ) |
Nächstes Ertragsdatum | ( €1.910 ) 2024-05-15 |
Last Dividend | €2.20 ( 2023-05-02 ) |
Next Dividend | €0 ( N/A ) |
P/E | 23.04 |
ATR14 | €0.0480 (0.03%) |
Volumen Korrelation
Merck KGaA Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Merck KGaA Korrelation - Währung/Rohstoff
Merck KGaA Finanzdaten
Annual | 2023 |
Umsatz: | €20.99B |
Bruttogewinn: | €11.67B (55.59 %) |
EPS: | €6.50 |
FY | 2023 |
Umsatz: | €20.99B |
Bruttogewinn: | €11.67B (55.59 %) |
EPS: | €6.50 |
FY | 2022 |
Umsatz: | €22.23B |
Bruttogewinn: | €13.71B (61.65 %) |
EPS: | €7.65 |
FY | 2021 |
Umsatz: | €19.69B |
Bruttogewinn: | €12.34B (62.66 %) |
EPS: | €7.03 |
Financial Reports:
No articles found.
Merck KGaA Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€2.20 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.418 | 2000-05-12 |
Last Dividend | €2.20 | 2023-05-02 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 25 | -- |
Total Paid Out | €22.03 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.52 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.03 | |
Div. Directional Score | 9.24 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PRU.DE | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% | |
AUS.DE | Ex Dividend Junior | 2023-07-25 | Annually | 0 | 0.00% | |
HRS.DE | Ex Dividend Knight | 2023-09-01 | Quarterly | 0 | 0.00% | |
SNW.DE | Ex Dividend Junior | 2023-05-30 | Annually | 0 | 0.00% | |
CHV.DE | Ex Dividend King | 2023-08-17 | Quarterly | 0 | 0.00% | |
KTF.DE | Ex Dividend Knight | 2023-06-29 | Quarterly | 0 | 0.00% | |
UTDI.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
DWS.DE | Ex Dividend Knight | 2023-06-16 | Annually | 0 | 0.00% | |
NKE.DE | Ex Dividend King | 2023-09-01 | Quarterly | 0 | 0.00% | |
8TRA.DE | Ex Dividend Junior | 2023-06-02 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.135 | 1.500 | 7.31 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0575 | 1.200 | 8.08 | 9.70 | [0 - 0.3] |
returnOnEquityTTM | 0.105 | 1.500 | 9.95 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.440 | -1.000 | 5.60 | -5.60 | [0 - 1] |
currentRatioTTM | 1.425 | 0.800 | 7.88 | 6.30 | [1 - 3] |
quickRatioTTM | 0.822 | 0.800 | 9.87 | 7.90 | [0.8 - 2.5] |
cashRatioTTM | 0.228 | 1.500 | 9.85 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.194 | -1.500 | 6.76 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 11.33 | 1.000 | 6.92 | 6.92 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.70 | 2.00 | 7.10 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 4.52 | 2.00 | 7.74 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.358 | -1.500 | 8.57 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.590 | 1.000 | 3.50 | 3.50 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.182 | 1.000 | 8.36 | 8.36 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.396 | 1.000 | 8.91 | 8.91 | [0.2 - 2] |
assetTurnoverTTM | 0.427 | 0.800 | -0.484 | -0.387 | [0.5 - 2] |
Total Score | 12.44 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 22.92 | 1.000 | 7.79 | 0 | [1 - 100] |
returnOnEquityTTM | 0.105 | 2.50 | 9.97 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 4.52 | 2.00 | 8.49 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.477 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.70 | 2.00 | 7.10 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.440 | 1.500 | 5.60 | -5.60 | [0 - 1] |
pegRatioTTM | 0.115 | 1.500 | -2.57 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.180 | 1.000 | 7.99 | 0 | [0.1 - 0.5] |
Total Score | 6.03 |
Merck KGaA
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.